“Vasopressin Injection, USP.” FDA.gov, U.S. Food and Drug Administration, 2023, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204485s003lbl.pdf.
Vail EA, Gershengorn HB, Hua M, Walkey AJ, Wunsch H. Epidemiology of Vasopressin Use for Adults with Septic Shock. Ann Am Thorac Soc. 2016 Oct;13(10):1760-1767. doi: 10.1513/AnnalsATS.201604-259OC. PMID: 27404213; PMCID: PMC5122493.
Link to Article
Link to FULL FREE PDF
Caldwell HK, Lee HJ, Macbeth AH, Young WS 3rd. Vasopressin: behavioral roles of an “original” neuropeptide. Prog Neurobiol. 2008 Jan;84(1):1-24. doi: 10.1016/j.pneurobio.2007.10.007. Epub 2007 Nov 4. PMID: 18053631; PMCID: PMC2292122.
Link to Article
Link to FULL FREE PDF
Shampo MA, Kyle RA, Steensma DP. Stamp vignette on medical science. Vincent du Vigneaud-Nobel Prize in chemistry. Mayo Clin Proc. 2013 Sep;88(9):e99. doi: 10.1016/j.mayocp.2012.01.032. PMID: 24001505.
Link to Article
Link to FULL FREE PDF
Bendicksen L, Kesselheim AS, Rome BN. The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs. Chest. 2022 Aug;162(2):433-435. doi: 10.1016/j.chest.2022.02.048. PMID: 35940656; PMCID: PMC9353103.
Link to Article
Link to FULL FREE PDF
Demiselle J, Fage N, Radermacher P, Asfar P. Vasopressin and its analogues in shock states: a review. Ann Intensive Care. 2020 Jan 22;10(1):9. doi: 10.1186/s13613-020-0628-2. PMID: 31970567; PMCID: PMC6975768.
Link to Article
Link to FULL FREE PDF
Kaufmann JE, Oksche A, Wollheim CB, Günther G, Rosenthal W, Vischer UM. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest. 2000 Jul;106(1):107-16. doi: 10.1172/JCI9516. PMID: 10880054; PMCID: PMC314363.
Link to Article
Link to FULL FREE PDF
Glavaš M, Gitlin-Domagalska A, Dębowski D, Ptaszyńska N, Łęgowska A, Rolka K. Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides. Int J Mol Sci. 2022 Mar 12;23(6):3068. doi: 10.3390/ijms23063068. PMID: 35328489; PMCID: PMC8955888.
Link to Article
Link to FULL FREE PDF
Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D’Alessandro D, Oz MC, Oliver JA. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997 Mar 4;95(5):1122-5. doi: 10.1161/01.cir.95.5.1122. PMID: 9054839.
Link to Article and FULL FREE EPUB
Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999 Oct;47(4):699-703; discussion 703-5. doi: 10.1097/00005373-199910000-00014. PMID: 10528604.
Link to Article and FULL FREE PDF
Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003 May 13;107(18):2313-9. doi: 10.1161/01.CIR.0000066692.71008.BB. Epub 2003 May 5. PMID: 12732600.
Link to Article
Link to FULL FREE PDF
Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002 Mar;96(3):576-82. doi: 10.1097/00000542-200203000-00011. PMID: 11873030.
Link to Article
Link to FULL FREE PDF
Luckner G, Mayr VD, Jochberger S, Wenzel V, Ulmer H, Hasibeder WR, Dünser MW. Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock. Crit Care Med. 2007 Oct;35(10):2280-5. doi: 10.1097/01.ccm.0000281853.50661.23. PMID: 17944015.
Link to (NOT FREE) Article
Vasopressin Injection, USP.” FDA.gov, U.S. Food and Drug Administration, 2023, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204485s003lbl.pdf.
Tayama E, Ueda T, Shojima T, Akasu K, Oda T, Fukunaga S, Akashi H, Aoyagi S. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg. 2007 Dec;6(6):715-9. doi: 10.1510/icvts.2007.159624. Epub 2007 Aug 17. PMID: 17704123.
Link to Article
Link to FULL FREE PDF
Sparapani S, Millet-Boureima C, Oliver J, Mu K, Hadavi P, Kalostian T, Ali N, Avelar CM, Bardies M, Barrow B, Benedikt M, Biancardi G, Bindra R, Bui L, Chihab Z, Cossitt A, Costa J, Daigneault T, Dault J, Davidson I, Dias J, Dufour E, El-Khoury S, Farhangdoost N, Forget A, Fox A, Gebrael M, Gentile MC, Geraci O, Gnanapragasam A, Gomah E, Haber E, Hamel C, Iyanker T, Kalantzis C, Kamali S, Kassardjian E, Kontos HK, Le TBU, LoScerbo D, Low YF, Mac Rae D, Maurer F, Mazhar S, Nguyen A, Nguyen-Duong K, Osborne-Laroche C, Park HW, Parolin E, Paul-Cole K, Peer LS, Philippon M, Plaisir CA, Porras Marroquin J, Prasad S, Ramsarun R, Razzaq S, Rhainds S, Robin D, Scartozzi R, Singh D, Fard SS, Soroko M, Soroori Motlagh N, Stern K, Toro L, Toure MW, Tran-Huynh S, Trépanier-Chicoine S, Waddingham C, Weekes AJ, Wisniewski A, Gamberi C. The Biology of Vasopressin. Biomedicines. 2021 Jan 18;9(1):89. doi: 10.3390/biomedicines9010089. PMID: 33477721; PMCID: PMC7832310.
Link to Article
Link to FULL FREE PDF
Garcia B, Legrand M. Adjunctive vasopressors in distributive shock: How soon is early? Crit Care. 2023 May 30;27(1):210. doi: 10.1186/s13054-023-04500-y. PMID: 37254175; PMCID: PMC10230760.
Link to Article
Link to FULL FREE PDF
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Møller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2. PMID: 34599691; PMCID: PMC8486643.
Link to Article
Link to FULL FREE PDF
Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, Mason AJ, Ashby D, Gordon AC. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med. 2019 Jun;45(6):844-855. doi: 10.1007/s00134-019-05620-2. Epub 2019 May 6. PMID: 31062052.
Link to Article
Link to FULL FREE PDF
Arginine Vasopressin in Advanced Vasodilatory Shock. A Prospective, Randomized, Controlled Study.
Martin W. Dünser, Andreas J. Mayr, Hanno Ulmer, Hans Knotzer, Günther Sumann, Werner Pajk, Barbara Friesenecker and Walter R. Hasibeder
Originally published 5 May 2003https://doi.org/10.1161/01.CIR.0000066692.71008.BBCirculation. 2003;107:2313–2319
Link to Article
Link to FULL FREE PDF
McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, Lamontagne F, Healey JS, Whitlock RP, Belley-Côté EP. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA. 2018 May 8;319(18):1889-1900. doi: 10.1001/jama.2018.4528. PMID: 29801010; PMCID: PMC6583502.
Link to Article and FULL FREE PDF
Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373. PMID: 18305265.
Link to Article
Link to FULL FREE PDF
Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ; Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med. 2009 Mar;37(3):811-8. doi: 10.1097/CCM.0b013e3181961ace. PMID: 19237882.
Link to (NOT FREE) Article
Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ; VANISH Investigators. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485. PMID: 27483065.
Link to Article
Link to FULL FREE PDF
Lauzier F, Lévy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006 Nov;32(11):1782-9. doi: 10.1007/s00134-006-0378-0. Epub 2006 Sep 22. PMID: 17019548.
Link to (NOT FREE) Article
Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, Park CHL, Fukushima JT, Rizk SI, Szeles TF, Dos Santos Neto NC, Filho RK, Galas FRBG, Landoni G. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial. Crit Care Med. 2019 Dec;47(12):1743-1750. doi: 10.1097/CCM.0000000000004023. PMID: 31609774.
Link to Article
Link to FULL FREE PDF
Stolk RF, van der Poll T, Angus DC, van der Hoeven JG, Pickkers P, Kox M. Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis. Am J Respir Crit Care Med. 2016 Sep 1;194(5):550-8. doi: 10.1164/rccm.201604-0862CP. PMID: 27398737.
Link to Article
Link to FULL FREE PDF
Russell JA, Fjell C, Hsu JL, Lee T, Boyd J, Thair S, Singer J, Patterson AJ, Walley KR. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am J Respir Crit Care Med. 2013 Aug 1;188(3):356-64. doi: 10.1164/rccm.201302-0355OC. PMID: 23796235.
Link to Article
Link to FULL FREE PDF
Bauer SR, Sacha GL, Lam SW, Wang L, Reddy AJ, Duggal A, Vachharajani V. Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock. J Intensive Care Med. 2022 Jan;37(1):92-99. doi: 10.1177/0885066620977181. Epub 2020 Nov 28. PMID: 33251906; PMCID: PMC10243460.
Link to Article
Link to FULL FREE PDF
Möhring J, Glänzer K, Maciel JA Jr, Düsing R, Kramer HJ, Arbogast R, Koch-Weser J. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):367-76. doi: 10.1097/00005344-198007000-00004. PMID: 6156335.
Link to Article and FULL FREE PDF
Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock. Crit Care Med. 2022 Apr 1;50(4):614-623. doi: 10.1097/CCM.0000000000005317. PMID: 34582425.
Link to (NOT FREE) Article
Bauer SR, Sacha GL, Siuba MT, Lam SW, Reddy AJ, Duggal A, Vachharajani V. Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study. Crit Care Explor. 2022 Feb 8;4(2):e0634. doi: 10.1097/CCE.0000000000000634. PMID: 35156051; PMCID: PMC8826954.
Link to Article and FULL FREE PDF
Yimin H, Xiaoyu L, Yuping H, Weiyan L, Ning L. The effect of vasopressin on the hemodynamics in CABG patients. J Cardiothorac Surg. 2013 Mar 16;8:49. doi: 10.1186/1749-8090-8-49. PMID: 23497457; PMCID: PMC3610232.
Link to Article
Link to FULL FREE PDF
Jeon Y, Ryu JH, Lim YJ, Kim CS, Bahk JH, Yoon SZ, Choi JY. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardiothorac Surg. 2006 Jun;29(6):952-6. doi: 10.1016/j.ejcts.2006.02.032. Epub 2006 May 3. PMID: 16675238.
Link to Article
Link to FULL FREE PDF
Wu Z, Zhang S, Xu J, Xie J, Huang L, Huang Y, Yang Y, Qiu H. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis. Shock. 2020 Jan;53(1):50-57. doi: 10.1097/SHK.0000000000001345. PMID: 31008869.
Link to Article and FULL FREE PDF
Boyd JH, Holmes CL, Wang Y, Roberts H, Walley KR. Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R. Resuscitation. 2008 Nov;79(2):325-31. doi: 10.1016/j.resuscitation.2008.07.006. PMID: 18951114.
Link to (NOT FREE) Article
Young PJ, Delaney A, Venkatesh B. Vasopressin in septic shock: what we know and where to next? Intensive Care Med. 2019 Jun;45(6):902-903. doi: 10.1007/s00134-019-05642-w. Epub 2019 May 13. PMID: 31087112.
Link to Article
Link to FULL FREE PDF
Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004 Jul;30(7):1276-91. doi: 10.1007/s00134-004-2283-8. Epub 2004 Apr 21. PMID: 15103461.
https://link.springer.com/article/10.1007/s00134-004-2283-8
Dünser MW, Mayr AJ, Wenzel V, Hasibeder WR. Comment on “Role of vasopressin in the management of septic shock” by Mutlu and Factor. Intensive Care Med. 2004 Oct;30(10):1982; author reply 1983. doi: 10.1007/s00134-004-2394-2. Epub 2004 Jul 23. PMID: 15278269.
https://link.springer.com/article/10.1007/s00134-004-2394-2
Dunser MW, Wenzel V, Mayr AJ, Hasibeder WR. Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs. 2003;63(3):237-56. doi: 10.2165/00003495-200363030-00001. PMID: 12534330.
https://link.springer.com/article/10.2165/00003495-200363030-00001
